These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31935477)

  • 1. New nanoparticles for topical ocular delivery of erythropoietin.
    Silva B; Marto J; Braz BS; Delgado E; Almeida AJ; Gonçalves L
    Int J Pharm; 2020 Feb; 576():119020. PubMed ID: 31935477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan and Hyaluronic Acid Nanoparticles as Vehicles of Epoetin Beta for Subconjunctival Ocular Delivery.
    Silva B; Gonçalves LM; Braz BS; Delgado E
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
    Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
    Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.
    Resende AP; Silva B; Braz BS; Nunes T; Gonçalves L; Delgado E
    Drug Deliv Transl Res; 2017 Oct; 7(5):625-631. PubMed ID: 28639139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
    Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
    Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 12. Encapsulation and controlled release of recombinant human erythropoietin from chitosan-carrageenan nanoparticles.
    Bulmer C; Margaritis A; Xenocostas A
    Curr Drug Deliv; 2012 Sep; 9(5):527-37. PubMed ID: 22812393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
    Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
    Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin encapsulation in chitosan nanoparticles and kinetics of drug release.
    Bokharaei M; Margaritis A; Xenocostas A; Freeman DJ
    Curr Drug Deliv; 2011 Mar; 8(2):164-71. PubMed ID: 21235481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
    Deng F; Hu W; Chen H; Tang Y; Zhang L
    Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular anti-inflammatory activity of prednisolone acetate loaded chitosan-deoxycholate self-assembled nanoparticles.
    Hanafy AF; Abdalla AM; Guda TK; Gabr KE; Royall PG; Alqurshi A
    Int J Nanomedicine; 2019; 14():3679-3689. PubMed ID: 31239660
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.
    Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM
    Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
    Zhou W; Wang Y; Jian J; Song S
    Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.